Skip to the page

Data / Medical devices / France / Milvue

Milvue: FDA-registered device maker in Paris Ile-de-France, France, 2 510(k) clearances

Milvue is registered with the FDA (registration 3027453703) in Paris Ile-de-France, France. It lists 2 device types. The FDA files 2 510(k) clearances under its listings, the newest dated January 17, 2025. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3027453703
Address
35 rue Vaugelas, Paris Ile-de-France, France, 75015
Owner or operator
Milvue (10092068)
Roles
Manufacturer
First device listed
December 1, 2024
Registered through
2026
Brand names listed
SmartChest, TechCare Trauma

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
January 17, 2025K242171TechCare TraumaQBSSubstantially EquivalentMilvueaccessdata.fda.gov
May 10, 2024K232410SmartChestQFMSubstantially EquivalentMilvueaccessdata.fda.gov

Compare with other makers

Updated January 17, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.